Where is EUROIMMUN located?

EUROIMMUN is headquartered in Lubeck, Germany.

How many employees does EUROIMMUN have?

As of Aug 31, 2026, the latest employee count at EUROIMMUN is 838.

Where does EUROIMMUN rank among its competitors?

EUROIMMUN ranks 80th amongst 433 active competitors, of which 95 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Daye, which secured $576K in Nov, 2025.

Who are the top competitors of EUROIMMUN?

EUROIMMUN's top competitors include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Among them, Daye secured the most recent funding round in November, 2025.

EUROIMMUN - 2026 Company Profile, Team, Funding & Competitors

Q: Is EUROIMMUN an acquired company?

EUROIMMUN got acquired by PerkinElmer on Jun 19, 2017.

Company Details

EUROIMMUN AG, part of PerkinElmer, provides test and automation systems for medical laboratory diagnostics. The company provides a range of tests for the fields of autoimmunity, allergies, infections, molecular diagnostic detections, and antigen-proofs. Their tests include ELISA, rapid tests, biomarker detections, and others.

Website: www.euroimmun.de/
Social
Email ID: *****@euroimmun.de
Phone Number: +49 **********
Part Of

Key Metrics

Founded Year

1987

Location

Lubeck, Germany

Stage

Acquired

Investors

Haspa BGM & 1 more

Ranked

80^th among 433 active competitors

Employee Count

838 as on Aug 31, 2026

Similar Companies

Adaptive Biotechnologies & 502 more

Exit Details

Acquired by PerkinElmer (Jun 19, 2017)

View EUROIMMUN's full profile

EUROIMMUN got acquired by PerkinElmer on Jun 19, 2017 at an acquisition amount of $*****.

Click here to take a look at EUROIMMUN's acquisition in detail

EUROIMMUN is a funded company. EUROIMMUN has 2 institutional investors.

View details of EUROIMMUN's funding rounds and investors

The founders of EUROIMMUN is Winfried Stocker.

Here are the details of EUROIMMUN's key team members:

Winfried Stocker: Founder of EUROIMMUN and founder of 1 other company.

View details of EUROIMMUN's Founder profiles and Board Members

EUROIMMUN's employee count trend

EUROIMMUN has 838 employees as of Aug 26. Here is EUROIMMUN's employee count trend over the years:

Uncover EUROIMMUN's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of EUROIMMUN include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Here is the list of Top 10 competitors of EUROIMMUN, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Adaptive Biotechnologies 2009, Seattle (United States), Public	Provider of clinical diagnostics, and drug discovery for immune diseases	$419M	Viking Global Investors, Matrix & 21 others	72/100
2nd	MeMed 2009, Tirat Carmel (Israel), Series D	Provider of machine learning based diagnostic solutions for infectious diseases	$163M	La Maison Partners, Ping An & 23 others	69/100
3rd	HaystackAnalytics 2018, Mumbai (India), Seed	Provider of genomics technology for personalized clinical decisions	$17.3M	STRIVE, Sun Pharma & 33 others	67/100
4th	Exagen 2002, Vista (United States), Public	Developer of diagnosis, prognosis and monitoring solutions for autoimmune connective diseases	$110M	HIG BioHealth Partners, Tullis Health Investors ... & 10 others	65/100
5th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
6th	Karius 2014, Redwood City (United States), Series C	Provider of diagnostics for identifying infectious diseases using microbial DNA	$315M	Khosla Ventures, Gilde Healthcare & 16 others	58/100
7th	Mylab 2016, Pune (India), Seed	Developer of diagnostic kits for pathogen detection and viral load monitoring	-	Rising Sun Holdings, Zydus Life & 10 others	57/100
8th	Seegene Technologies 2000, Seoul (South Korea), Public	Provider of advanced molecular diagnostics solutions	-	IMM Investment, Songhyun Investment & 3 others	56/100
9th	Daye 2018, London (United Kingdom), Series A	Manufacturer of period care products and provider of health tests	$19.2M	Salica Investments, Kindred Capital & 24 others	56/100
10th	Clear Labs 2014, Menlo Park (United States), Series D	Provider of food safety technologies for the identification of pathogens	$171M	Menlo Ventures, Redmile Group & 26 others	56/100
80th	EUROIMMUN 1987, Lubeck (Germany), Acquired	Provider of test and automation systems for medical laboratory diagnostics	-	Haspa BGM, COI Partners	37/100